Analyze Diet

Development of a novel in vitro equine anthelmintic assay.

Abstract: An in vitro assay involving the use of a horse strongyle (Strongylus edentatus) and the micromotility meter has been developed to test for equine anthelmintic activity. Three commercially available equine anthelmintics (dichlorvos, ivermectin, and pyrantel pamoate) and an investigational drug (p-toluoyl chloride phenylhydrazone) were evaluated in this assay at four concentrations. After a 24-h incubation, greater than or equal to 10 micrograms/ml of all four drug treatments significantly (P less than or equal to 0.05) reduced the motility of ensheathed L-3 S. edentatus larvae, thereby indicating anthelmintic activity. Pyrantel pamoate also reduced motility at 1 microgram/ml, while the hydrazone significantly increased movement at this level. At 0.1 microgram/ml, none of the treatments significantly reduced motility; one treatment (dichlorvos) significantly increased larval motility. Incubation for 48 h resulted in significant activity (reduction in motility) at greater than or equal to 1 microgram/ml with two drugs (ivermectin, pyrantel pamoate); dichlorvos and the hydrazone reduced motility at greater than or equal to 10 micrograms/ml. None of the treatments significantly reduced motility at the lowest concentration (0.1 microgram/ml); however, at 48 h, two treatments (dichlorvos, hydrazone) significantly increased motility at the lowest concentration (0.1 microgram/ml). The in vitro S. edentatus motility assay proved to be sensitive, accurate and rapid. This assay system should be a valuable addition to tests used to identify potential equine anthelmintics, monitor helminth resistance to drugs, and perhaps define the kinetics and mode of action for drugs.
Publication Date: 1988-06-01 PubMed ID: 3184256
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents the development of a new laboratory method that uses horse parasites and a micromotility meter to test the effectiveness of worm treatments for horses.

Introduction and Methodology

  • The study introduces a novel in vitro (lab-based) assay or test. In this assay, the researchers use a horse parasite known as Strongylus edentatus along with a micromotility meter, which is a device for measuring small movements.
  • The aim of the test is to measure the anthelmintic activity or effectiveness of different drugs used for treating worm infestations in horses.
  • The researchers tested the anthelmintic activity of three commercially available worm treatments for horses (dichlorvos, ivermectin, and pyrantel pamoate), as well as an experimental drug (p-toluoyl chloride phenylhydrazone).
  • These drugs were evaluated at four different concentrations, and the effects were observed over a 24-hour incubation period.

Results

  • The research found that when the drugs were used at concentrations greater than or equal to 10 micrograms/ml, all four treatments significantly reduced the motility or movement of the Strongylus edentatus larvae, thus indicating their anthelmintic activity.
  • When used at a concentration of 1 microgram/ml, pyrantel pamoate was still effective in reducing motility. However, the experimental drug, hydrazone, increased movement at this concentration, which implies it may not be effective or could even stimulate the parasites in actual practice.
  • At the lowest concentration level of 0.1 micrograms/ml tested, none of the treatments reduced motility significantly. In fact, dichlorvos was observed to increase larval motility at this concentration.

Extended Observations

  • On extending the incubation period to 48 hours, two drugs – ivermectin and pyrantel pamoate, were effective at a lower concentration of 1 microgram/ml, reducing the motility of the larvae. Dichlorvos and the hydrazone drug, however, only had a noticeable effect at a concentration of 10 micrograms/ml or higher.
  • At the lowest test concentration (0.1 microgram/ml), and after 48 hours of incubation, none of the treatments significantly reduced motility. But two treatments – dichlorvos and the hydrazone drug, resulted in increased motility at this low concentration.

Study Implications

  • This newly developed assay was found to be sensitive, accurate, and rapid, making it a potential valuable tool for testing the effectiveness of worm treatments for horses.
  • Such an assay could also be used to identify new potential anthelmintics, monitor worm resistance to current drugs and even help understand the behavior and specific mode of action of these drugs.

Cite This Article

APA
Folz SD, Pax RA, Klei TR, Thomas EM, Ash KA, Conder GA, Bennett JL. (1988). Development of a novel in vitro equine anthelmintic assay. J Vet Pharmacol Ther, 11(2), 177-182.

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 11
Issue: 2
Pages: 177-182

Researcher Affiliations

Folz, S D
  • Upjohn Company, Kalamazoo, Michigan 49001.
Pax, R A
    Klei, T R
      Thomas, E M
        Ash, K A
          Conder, G A
            Bennett, J L

              MeSH Terms

              • Animals
              • Anthelmintics / pharmacology
              • Dichlorvos / pharmacology
              • Feces / parasitology
              • Horses
              • Hydrazones / pharmacology
              • In Vitro Techniques
              • Ivermectin / pharmacology
              • Larva
              • Pyrantel Pamoate / pharmacology
              • Strongyle Infections, Equine / parasitology
              • Strongyloidea / drug effects
              • Strongylus / drug effects
              • Time Factors

              Citations

              This article has been cited 0 times.